FBT
CLB icon

First Bank & Trust’s Core Laboratories CLB Stock Holding History

First Bank & Trust’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,843
Closed -$56K – 227
2022
Q2 		$56K Buy
2,843
+282
+11% +$7.49K 0.02% 278
2022
Q1 		$81K Buy
2,561
+456
+22% +$12.8K 0.03% 267
2021
Q4 		$47K Sell
2,105
-314
-13% -$8.19K 0.02% 277
2021
Q3 		$67K Sell
2,419
-195
-7% -$5.94K 0.03% 257
2021
Q2 		$101K Buy
2,614
+228
+10% +$8.17K 0.05% 231
2021
Q1 		$69K Buy
2,386
+165
+7% +$5.64K 0.03% 251
2020
Q4 		$59K Sell
2,221
-786
-26% -$16.1K 0.04% 240
2020
Q3 		$46K Buy
3,007
+1,832
+156% +$38.4K 0.03% 251
2020
Q2 		$24K Sell
1,175
-1,080
-48% -$19.4K 0.02% 265
2020
Q1 		$23K Sell
2,255
-207
-8% -$5.79K 0.02% 275
2019
Q4 		$93K Sell
2,462
-728
-23% -$32.7K 0.07% 184
2019
Q3 		$148K Buy
3,190
+338
+12% +$15.7K 0.11% 157
2019
Q2 		$149K Buy
2,852
+492
+21% +$28.9K 0.12% 151
2019
Q1 		$163K Buy
2,360
+517
+28% +$34.7K 0.13% 152
2018
Q4 		$110K Buy
1,843
+110
+6% +$9.49K 0.09% 171
2018
Q3 		$198K Buy
1,733
+105
+6% +$11.8K 0.15% 145
2018
Q2 		$206K Buy
1,628
+101
+7% +$12.3K 0.16% 138
2018
Q1 		$166K Sell
1,527
-21
-1% -$2.32K 0.13% 155
2017
Q4 		$170K Sell
1,548
-120
-7% -$12K 0.13% 151
2017
Q3 		$165K Buy
1,668
+175
+12% +$17K 0.13% 151
2017
Q2 		$152K Buy
1,493
+82
+6% +$8.84K 0.13% 149
2017
Q1 		$163K Buy
1,411
+37
+3% +$4.3K 0.14% 148
2016
Q4 		$165K Buy
+1,374
New +$152K 0.15% 144

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

First Bank & Trust's CLB Position: Q3 2022 in Review

First Bank & Trust sold out of Core Laboratories (CLB) in Q3 2022, closing a stake of 2,843 shares — an estimated $56K sold.

First Bank & Trust first reported a position in CLB in Q4 2016 and held it in 23 quarters. The position peaked at $206K in Q2 2018. 162 funds tracked by Wall St. Rank hold CLB as of Q3 2022.

  • First Bank & Trust reported no remaining Core Laboratories position as of Q3 2022 after selling out during the quarter.
  • First Bank & Trust sold 2,843 Core Laboratories shares in Q3 2022, an estimated $56K.
  • First Bank & Trust first reported a position in Core Laboratories in Q4 2016 and held it in 23 quarters.
  • First Bank & Trust's Core Laboratories position peaked at $206K in Q2 2018.
  • 162 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2022.

Based on First Bank & Trust's 13F filing for Q3 2022, filed 28 Oct 2022.